Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blockade of Organic Anion Transport in Humans After Treatment With the Drug Probenecid Leads to Major Metabolic Alterations in Plasma and Urine
Jeffry C. Granados, Vibha Bhatnagar, Sanjay K. Nigám
Clinical Pharmacology & Therapeutics (2022) Vol. 112, Iss. 3, pp. 653-664
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review
Robert Terkeltaub
Drugs (2023) Vol. 83, Iss. 16, pp. 1501-1521
Closed Access | Times Cited: 32
Gout therapeutics and drug delivery
Xiuju Peng, Xiaotong Li, Bing Xie, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 728-754
Closed Access | Times Cited: 24
Clinical Assessment of Drug Transporter Inhibition Using Biomarkers: Review of the Literature (2015–2024)
David Rodrigues, Stephanie Wezalis
The Journal of Clinical Pharmacology (2025)
Closed Access | Times Cited: 1
OAT, OATP, and MRP Drug Transporters and the Remote Sensing and Signaling Theory
Sanjay K. Nigám, Jeffry C. Granados
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 637-660
Open Access | Times Cited: 31
The substrate and inhibitor binding mechanism of polyspecific transporter OAT1 revealed by high-resolution cryo-EM
Tong‐Yi Dou, Tengfei Lian, Shi Shu, et al.
Nature Structural & Molecular Biology (2023) Vol. 30, Iss. 11, pp. 1794-1805
Open Access | Times Cited: 20
A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter‐Mediated Drug‐Drug Interactions
Arne Gessner, Fabian Müller, Pia Wenisch, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 5, pp. 1058-1072
Open Access | Times Cited: 14
Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout
Zihan Hou, Aijinxiu Ma, Jiale Mao, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 12, pp. 895-909
Closed Access | Times Cited: 14
The Role of Coproporphyrins As Endogenous Biomarkers for Organic Anion Transporting Polypeptide 1B Inhibition–Progress from 2016 to 2023
Yurong Lai
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 8, pp. 950-961
Open Access | Times Cited: 13
From discovery to translation: Endogenous substrates of OAT1 and OAT3 as clinical biomarkers for renal secretory function
Aarzoo Thakur, Dilip Kumar Singh, Katherine Hart, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Pyridoxic Acid as Endogenous Biomarker of Renal Organic Anion Transporter Activity: Population Variability and Mechanistic Modeling to Predict Drug–Drug Interactions
Aarzoo Thakur, Sumathy Mathialagan, Emi Kimoto, et al.
CPT Pharmacometrics & Systems Pharmacology (2025)
Open Access
Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: Discovery of putative organic anion transporter biomarkers
Aarzoo Thakur, Vijaya Saradhi Mettu, Dilip Kumar Singh, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115867-115867
Closed Access | Times Cited: 10
The kidney drug transporter OAT1 regulates gut microbiome–dependent host metabolism
Jeffry C. Granados, Vladimir Ermakov, Koustav Maity, et al.
JCI Insight (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 9
Lacticaseibacillus paracasei JS-3 Isolated from “Jiangshui” Ameliorates Hyperuricemia by Regulating Gut Microbiota and iTS Metabolism
Jiahui Wu, Lvbu Aga, Leimengyuan Tang, et al.
Foods (2024) Vol. 13, Iss. 9, pp. 1371-1371
Open Access | Times Cited: 3
In Vivo Regulation of Small Molecule Natural Products, Antioxidants, and Nutrients by OAT1 and OAT3
Kian Falah, Patrick Zhang, Anisha K. Nigam, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2242-2242
Open Access | Times Cited: 3
Suppression of Indoxyl Sulfate Accumulation Reduces Renal Fibrosis in Sulfotransferase 1a1-Deficient Mice
Huixian Hou, Mai Horikawa, Yuki Narita, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11329-11329
Open Access | Times Cited: 8
Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma
Thomas Whisenant, Sanjay K. Nigám
Cancers (2022) Vol. 14, Iss. 19, pp. 4772-4772
Open Access | Times Cited: 13
New Biomarkers for Renal Transporter‐Mediated Drug–Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans
Arne Gessner, Jörg König, Pia Wenisch, et al.
Clinical Pharmacology & Therapeutics (2024)
Open Access | Times Cited: 2
Organic anion transporters in remote sensing and organ crosstalk
Jeffry C. Granados, Sanjay K. Nigám
Pharmacology & Therapeutics (2024), pp. 108723-108723
Open Access | Times Cited: 2
Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions
Neema Jamshidi, Sanjay K. Nigám
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
A Biological Basis for Pharmacokinetics: The Remote Sensing and Signaling Theory
Sanjay K. Nigám, Jeffry C. Granados
Clinical Pharmacology & Therapeutics (2022) Vol. 112, Iss. 3, pp. 456-460
Open Access | Times Cited: 11
Whey protein peptide PEW attenuates hyperuricemia and associated renal inflammation in potassium oxonate and hypoxanthine-induced rat
Xiaofen Qi, Yanfeng Ma, Kaifang Guan, et al.
Food Bioscience (2022) Vol. 51, pp. 102311-102311
Closed Access | Times Cited: 11
Regulation of Human Endogenous Metabolites by Drug Transporters and Drug Metabolizing Enzymes: An Analysis of Targeted SNP-Metabolite Associations
Jeffry C. Granados, Jeramie D. Watrous, Tao Long, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 171-171
Open Access | Times Cited: 6
Loss of the Kidney Urate Transporter, Urat1, Leads to Disrupted Redox Homeostasis in Mice
Neema Jamshidi, Kabir Nigam, Sanjay K. Nigám
Antioxidants (2023) Vol. 12, Iss. 3, pp. 780-780
Open Access | Times Cited: 5
Drug–Drug Interactions in Nosocomial Infections: An Updated Review for Clinicians
Sorina Hîncu, Miruna-Maria Apetroaei, G. Stefan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1137-1137
Open Access | Times Cited: 1
Metabolomic Profiling Identifies New Endogenous Markers of Tubular Secretory Clearance
Michael L. Granda, David K. Prince, Oliver Fiehn, et al.
Kidney360 (2022) Vol. 4, Iss. 1, pp. 23-31
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top